CALPROTECTIN KINETICS IN NORWEGIAN, HOSPITALIZED COVID-19 PATIENTS

CALPROTECTIN KINETICS IN NORWEGIAN, HOSPITALIZED COVID-19 PATIENTS

Intro: Activated neutrophils are proposedly linked to lung microcirculation damage in COVID-19 and increased neutrophil count is a risk factor for intensive care need and respiratory failure. Calprotectin and neutrophil extracellular traps (NETs) are neutrophil-derived, key inflammatory markers with...

Full description

Bibliographic Details
Main Authors:	G. Hetland, M. Fagerhol, M. Mirlashari, L.S. Nissen-Meyer
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971223006021

Similar Items

Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
by: Geir Hetland, et al.
Published: (2022-08-01)

Heterogeneity of Fecal Calprotectin Reflecting Generation of Neutrophil Extracellular Traps (NETs) in the Gut: New Immunoassays Are Available
by: Magne K. Fagerhol, et al.
Published: (2022-01-01)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
by: Walid Ellakany, et al.
Published: (2022-03-01)

3.5 IMPROVEMENT IN AORTIC STIFFNESS AFTER ONE YEAR OF ANTI-TUMOR NECROSIS FACTOR-α THERAPY IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES IS ASSOCIATED WITH REDUCTION IN CALPROTECTIN (A PROINFLAMMATORY S100 PROTEIN)
by: K. Angel, et al.
Published: (2009-12-01)

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
by: Gary L. Norman, et al.
Published: (2022-05-01)

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
by: Mentzer, AJ, et al.
Published: (2021)

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
by: Nicolas Chapuis, et al.
Published: (2022-06-01)

Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients
by: Giovanna Cardiero, et al.
Published: (2022-10-01)

Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID‐19
by: Haoran Zhang, et al.
Published: (2024-03-01)

Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
by: Deasy Natalia Adriana, et al.
Published: (2022-08-01)

Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
by: Hajar Shokri-Afra, et al.
Published: (2021-11-01)

Circulating calprotectin levels four months after severe and non-severe COVID-19
by: N. Abu Hussein, et al.
Published: (2023-10-01)

Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients.
by: Sophia Stanford, et al.
Published: (2023-01-01)

Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients
by: Sophia Stanford, et al.
Published: (2023-01-01)

Torrefaction Kinetics of Norwegian Biomass Fuels
by: Q.V. Bach, et al.
Published: (2014-06-01)

Fecal calprotectin and microbiota of the gut
by: V. G. Gorokhova, et al.
Published: (2016-07-01)

Calprotectin in Lung Diseases
by: Ourania S. Kotsiou, et al.
Published: (2021-02-01)

Calprotectin in systemic vasculitis
by: Pathare, S, et al.
Published: (2006)

Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis
by: Raphael Udeh, et al.
Published: (2021-02-01)

Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
by: Georgios Kassianidis, et al.
Published: (2022-04-01)

Ascitic fluid calprotectin and ratio of calprotectin to total protein in spontaneous bacterial peritonitis
by: Mai Mustafa Fahmy, et al.
Published: (2023-05-01)

The importance of serum calprotectin level in patients with lymphoma
by: Gülden Sincan, et al.
Published: (2023-01-01)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
by: Denise S. Riggers, et al.
Published: (2023-06-01)

Bacterial Responses to Iron Withholding by Calprotectin
by: Obisesan, Adunoluwa O, et al.
Published: (2022)

Fecal Calprotectin Is Increased in Stroke
by: Shin Young Park, et al.
Published: (2021-12-01)

COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
by: Mauro Giuffrè, et al.
Published: (2020-09-01)

Interpersonal Variability in Gut Microbial Calprotectin Metabolism
by: K. Kamp, et al.
Published: (2022-01-01)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
by: Miorita Melina Iordache, et al.
Published: (2023-07-01)

AZITHROMYCIN DECREASE SALIVA CALPROTECTIN IN PATIENTS WITH PERIODONTAL DISEASES.
by: Vladimir E. Panov, et al.
Published: (2014-03-01)

Determinants of Increased Serum Calprotectin in Patients with Type 2 Diabetes Mellitus
by: Milou M. Oosterwijk, et al.
Published: (2020-10-01)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
by: Matthias Jarlborg, et al.
Published: (2020-05-01)

The Norwegian sheep breeding scheme: description, genetic and phenotypic change
by: L.S. Eikje, et al.
Published: (2008-01-01)

Challenges and opportunities: impacts of COVID-19 on Norwegian seafood exports
by: Asche Frank, et al.
Published: (2022-01-01)

Medical Management in Norwegian Hospitals
by: Ivan Spehar, et al.
Published: (2012-06-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

Calprotectin in rheumatic diseases: a review
by: Magdalena Kopeć-Mędrek, et al.
Published: (2016-12-01)

Calprotectin--a novel marker of obesity.
by: Ole Hartvig Mortensen, et al.
Published: (2009-10-01)

Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01)

CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES
by: A. S. Avdeeva
Published: (2018-09-01)

Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients
by: Debby van Riel, et al.
Published: (2021-06-01)